Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine concentration comparison for TAP block after inguinal herniorrhaphy
PACTR202603797341811Phase 2Completed
- Sponsor
- Dr Anokwute Iheanyi
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bupivacaine in postoperative pain, sponsored by Dr Anokwute Iheanyi. Primary endpoint: Duration of analgesia. Started Apr 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202603797341811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603797341811.